Home > Products > CD55 & CA9
> Recombinant Anti-CD55 x Anti-CA9 Bispecific Antibody (scIgG)
Recombinant Anti-CD55 x Anti-CA9 Bispecific Antibody (scIgG) (CAT#: SCIGG-123)
Recombinant Anti-CD55 x Anti-CA9 Bispecific Antibody (scIgG) is designed to be expressed as two chains, each chain has the same units with their parental IgG antibodies, anti-CD55 and anti-CA9 IgGs. The two chains form heterodimer via Fc KIH technology. This BsAb can recruit complements to tumor cells. It is designed for the research of Renal cell cancer (RCC); Solid tumors therapy.
There are currently no customer reviews or questions for Recombinant Anti-CD55 x Anti-CA9 Bispecific Antibody (scIgG) (SCIGG-123). Click the button below to contact us or submit your feedback about this product.